Physician profile
Luan K DO
NPI 1538156245
$2,551.63
in general payments reported to CMS, 2019-2025
20 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,074 · 2020: $259 · 2021: $358 · 2022: $430 · 2023: $125 · 2024: $120 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $431.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $727.55 | 2019-2024 | Farxiga, Andexxa |
| Mallinckrodt Enterprises LLC | $301.18 | 2019 | |
| Amgen INC. | $184.01 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $179.30 | 2019-2020 | |
| Opko Pharmaceuticals, LLC | $162.06 | 2019-2022 | |
| Aurinia Pharma U.S., INC. | $159.67 | 2022 | |
| Fresenius USA Marketing, INC. | $128.98 | 2019-2022 | |
| Ardelyx, INC. | $121.84 | 2025 | Xphozah 30 Mg |
| Vifor Pharma, INC. | $101.48 | 2019-2022 | |
| Glaxosmithkline, LLC. | $90.01 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.22 | 2021-2022 | |
| Horizon Therapeutics Plc | $58.95 | 2019 | |
| Daiichi Sankyo INC. | $55.24 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $48.58 | 2019 | |
| Nxstage Medical, INC. | $42.98 | 2025 | Liberty Select Cycler, Nxstage System One |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $38.89 | 2020-2022 | |
| Akebia Therapeutics INC | $30.57 | 2019-2020 | |
| Allergan, INC. | $21.41 | 2019 | |
| Getinge USA Sales, LLC | $21.08 | 2025 | Cardiohelp |
| Travere Therapeutics, INC. | $15.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luan DO listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.